California is allocating up to $4 million to fund research exploring psychedelic treatments for veterans' mental health conditions, the Governor's office announced.
The funding will support partnerships between California research institutions and veteran communities through the California Initiative for Precision Medicine (CIAPM). Researchers will study personalized treatment approaches and work to address disparities in health outcomes.
Recent studies have shown certain psychedelics can treat depression, anxiety disorders, and substance use disorders, according to the state. Some research has demonstrated promise for treating veterans with PTSD.
The state, which is home to approximately 1.5 million veterans, will award up to $4 million in total funding over three to four years through a competitive request for applications process. Projects will advance precision medicineātreatments matched to individual patientsāand involve veterans directly in the research process.
"Veterans bring unique life experiences that can shape their health and treatment needs," said Lindsey Sin, Secretary of the California Department of Veterans Affairs. "By recognizing these experiences and engaging veterans directly in the research process, we can deepen our understanding of psychedelic treatments and their potential to improve health outcomes for those who have served."
According to the U.S. Department of Veterans Affairs, 41.9% of recent veteran users of VA health care had a documented mental health or substance use disorder diagnosis in 2021.
Applicants must submit a Letter of Intent by December 18, 2026, with initial applications due February 19, 2027. The funding was allocated through AB 113, marking the state's third consecutive year supporting psychedelic research legislation.
